itraconazole

Experimental Therapeutics
In Vivo Efficacy of Aerosolized Nanostructured Itraconazole Formulations for Prevention of Invasive Pulmonary Aspergillosis
Barbara J. Hoeben, David S. Burgess, Jason T. McConville, Laura K. Najvar, Robert L. Talbert, Jay I. Peters, Nathan P. Wiederhold, Bradi L. Frei, John R. Graybill, Rosie Bocanegra, Kirk A. Overhoff, Prapasri Sinswat, Keith P. Johnston, Robert O. Williams
Clinical Therapeutics
Open-Label, Randomized Comparison of Itraconazole versus Caspofungin for Prophylaxis in Patients with Hematologic Malignancies
Gloria N. Mattiuzzi, Gladys Alvarado, Francis J. Giles, Luis Ostrosky-Zeichner, Jorge Cortes, Susan O'Brien, Srdan Verstovsek, Stefan Faderl, Xian Zhou, Issam I. Raad, B. Nebiyou Bekele, G. J. Leitz, Ivonne Lopez-Roman, Elihu H. Estey
Analytical Procedures
Isocratic High-Performance Liquid Chromatographic Method with Ultraviolet Detection for Simultaneous Determination of Levels of Voriconazole and Itraconazole and Its Hydroxy Metabolite in Human Serum
GholamAli Khoschsorur, Franz Fruehwirth, Sieglinde Zelzer
Susceptibility
Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus
Manuel Cuenca-Estrella, Alicia Gomez-Lopez, Guillermo Garcia-Effron, Laura Alcazar-Fuoli, Emilia Mellado, Maria J. Buitrago, Juan L. Rodriguez-Tudela
Experimental Therapeutics
In Vitro Pharmacodynamics of Amphotericin B, Itraconazole, and Voriconazole against Aspergillus, Fusarium, and Scedosporium spp
Russell E. Lewis, Nathan P. Wiederhold, Michael E. Klepser
Mechanisms of Resistance
In Vitro Evolution of Itraconazole Resistance in Aspergillus fumigatus Involves Multiple Mechanisms of Resistance
Márcia Eliana da Silva Ferreira, José Luiz Capellaro, Everaldo dos Reis Marques, Iran Malavazi, David Perlin, Steven Park, James B. Anderson, Arnaldo L. Colombo, Beth A. Arthington-Skaggs, Maria Helena S. Goldman, Gustavo H. Goldman
Clinical Therapeutics
Intrapulmonary Pharmacokinetics and Pharmacodynamics of Itraconazole and 14-Hydroxyitraconazole at Steady State
John E. Conte, Jeffrey A. Golden, Juliana Kipps, Marina McIver, Elisabeth Zurlinden
Susceptibility
Effect of pH on the In Vitro Activities of Amphotericin B, Itraconazole, and Flucytosine against Aspergillus Isolates
D. T. A. Te Dorsthorst, J. W. Mouton, C. J. P. van den Beukel, H. A. L. van der Lee, J. F. G. M. Meis, P. E. Verweij
Clinical Therapeutics
Pharmacokinetics of Intravenous Itraconazole in Stable Hemodialysis Patients
John F. Mohr, Kevin W. Finkel, John H. Rex, Jose R. Rodriguez, Gerhard J. Leitz, Luis Ostrosky-Zeichner
Susceptibility
In Vitro Susceptibilities of Madurella mycetomatis to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2H- Tetrazolium Hydroxide (XTT) Assay
Abdalla O. A. Ahmed, Wendy W. J. van de Sande, Wim van Vianen, Alex van Belkum, Ahmed H. Fahal, Henri A. Verbrugh, Irma A. J. M. Bakker-Woudenberg

Main menu

User menu

Search

itraconazole

Pages